156 related articles for article (PubMed ID: 15954537)
21. Saccharomyces as a vaccine against systemic candidiasis.
Liu M; Clemons KV; Johansen ME; Martinez M; Chen V; Stevens DA
Immunol Invest; 2012; 41(8):847-55. PubMed ID: 22686468
[TBL] [Abstract][Full Text] [Related]
22. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.
Cutler JE; Corti M; Lambert P; Ferris M; Xin H
PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288
[TBL] [Abstract][Full Text] [Related]
23. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein.
Tavares D; Ferreira P; Arala-Chaves M
Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195
[TBL] [Abstract][Full Text] [Related]
24. Structural characterization of low molecular weight polysaccharide from Astragalus membranaceus and its immunologic enhancement in recombinant protein vaccine against systemic candidiasis.
Yang F; Xiao C; Qu J; Wang G
Carbohydr Polym; 2016 Jul; 145():48-55. PubMed ID: 27106150
[TBL] [Abstract][Full Text] [Related]
25. Effects of immune suppression in murine models of disseminated Candida glabrata and Candida tropicalis infection and utility of a synthetic peptide vaccine.
Xin H
Med Mycol; 2019 Aug; 57(6):745-756. PubMed ID: 30521033
[TBL] [Abstract][Full Text] [Related]
26. Oral immunization of mice against candidiasis.
Jensen J; Warner T; Johnson C; Balish E
J Infect Dis; 1996 Jul; 174(1):133-40. PubMed ID: 8655983
[TBL] [Abstract][Full Text] [Related]
27. Liposomes containing Candida albicans ribosomes as a prophylactic vaccine against disseminated candidiasis in mice.
Eckstein M; Barenholz Y; Bar LK; Segal E
Vaccine; 1997 Feb; 15(2):220-4. PubMed ID: 9066041
[TBL] [Abstract][Full Text] [Related]
28. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.
Xin H; Cutler JE
Clin Vaccine Immunol; 2011 Oct; 18(10):1656-67. PubMed ID: 21832099
[TBL] [Abstract][Full Text] [Related]
29. A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits.
Lipinski T; Wu X; Sadowska J; Kreiter E; Yasui Y; Cheriaparambil S; Rennie R; Bundle DR
Vaccine; 2012 Sep; 30(44):6263-9. PubMed ID: 22902677
[TBL] [Abstract][Full Text] [Related]
30. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
[TBL] [Abstract][Full Text] [Related]
31. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.
Vilanova M; Teixeira L; Caramalho I; Torrado E; Marques A; Madureira P; Ribeiro A; Ferreira P; Gama M; Demengeot J
Immunology; 2004 Mar; 111(3):334-42. PubMed ID: 15009435
[TBL] [Abstract][Full Text] [Related]
32. Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.
Segal E
Methods Mol Biol; 2017; 1625():343-353. PubMed ID: 28585001
[TBL] [Abstract][Full Text] [Related]
33. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
Schmidt CS; White CJ; Ibrahim AS; Filler SG; Fu Y; Yeaman MR; Edwards JE; Hennessey JP
Vaccine; 2012 Dec; 30(52):7594-600. PubMed ID: 23099329
[TBL] [Abstract][Full Text] [Related]
34. Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice.
Wang G; Sun M; Fang J; Yang Q; Tong H; Wang L
Vaccine; 2006 Aug; 24(35-36):6065-73. PubMed ID: 16842891
[TBL] [Abstract][Full Text] [Related]
35. A novel Th cell epitope of Candida albicans mediates protection from fungal infection.
Bär E; Gladiator A; Bastidas S; Roschitzki B; Acha-Orbea H; Oxenius A; LeibundGut-Landmann S
J Immunol; 2012 Jun; 188(11):5636-43. PubMed ID: 22529294
[TBL] [Abstract][Full Text] [Related]
36. A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis.
Thomas DP; Viudes A; Monteagudo C; Lazzell AL; Saville SP; López-Ribot JL
Proteomics; 2006 Nov; 6(22):6033-41. PubMed ID: 17051645
[TBL] [Abstract][Full Text] [Related]
37. An oral vaccine against candidiasis generated by a yeast molecular display system.
Shibasaki S; Aoki W; Nomura T; Miyoshi A; Tafuku S; Sewaki T; Ueda M
Pathog Dis; 2013 Dec; 69(3):262-8. PubMed ID: 23873745
[TBL] [Abstract][Full Text] [Related]
38. Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis.
Matthews R; Hodgetts S; Burnie J
J Infect Dis; 1995 Jun; 171(6):1668-71. PubMed ID: 7539475
[TBL] [Abstract][Full Text] [Related]
39. Serum antibody signature directed against Candida albicans Hsp90 and enolase detects invasive candidiasis in non-neutropenic patients.
Pitarch A; Nombela C; Gil C
J Proteome Res; 2014 Nov; 13(11):5165-84. PubMed ID: 25377742
[TBL] [Abstract][Full Text] [Related]
40. Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.
Xin H; Cartmell J; Bailey JJ; Dziadek S; Bundle DR; Cutler JE
PLoS One; 2012; 7(4):e35106. PubMed ID: 22563378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
